isabelobrien, Author at European Medical Journal - Page 4 of 65

Can the UK reclaim its status as a life sciences leader?

Two UK health leaders reveal how to boost life sciences R&D, attract investment and make the UK a global hub for innovation once more.

Cell-based flu vaccines could offer 20% more protection

CSL Seqirus real-world study finds cell-based flu vaccines offer stronger protection than egg-based options in 2023/24 season.

Lundbeck and Contera partner on RNA-targeted drug discovery

Lundbeck is partnering with Contera Pharma to accelerate RNA-targeted drug discovery for serious neurological conditions.

ViiV's bi-monthly HIV injection approved by NICE

Injectable HIV PrEP marks a breakthrough in prevention, providing a new option for patients in England unable to take daily pills.

Roche breaks world record for human genome sequencing

Roche has set a new Guinness World Record for the fastest DNA sequencing of a human genome, marking a major milestone in genomic innovation.

Inside the rise of HCP podcast engagement

HCP podcast engagement is growing fast. Explore EMJ data on audience trends, popular topics and how pharma can harness this powerful channel.

AstraZeneca to offer up to 80% off US drug prices

AstraZeneca joins Trump’s drug pricing plan, pledging $50bn US investment and discounts of up to 80% to cut prescription medicine costs.

Child using VR headset

NIHR funds £1.5m in innovative digital health projects

The UK’s NIHR has invested £1.5M in digital health to cut paediatric mental health waiting times.

Almirall’s Dr Volker Koscielny on World Mental Health Day

On World Mental Health Day, our latest Catalyst Dr Volker Koscielny calls for a new approach in dermatology – where well-being matters as much as clinical outcomes.

Could the brain be a target for autoimmune disease?

A new biotech company in New York, Nilo Therapeutics, believes the brain could hold the key to treating immune diseases.